Your browser doesn't support javascript.
loading
Multiple Myeloma Patients Ineligible for Randomized Controlled Trials Have Poorer Outcomes Irrespective of Treatment.
Malecek, Mary-Kate; Fiala, Mark; Schroeder, Mark; Dukeman, James; Ghobadi, Armin; Stockerl-Goldstein, Keith; Wildes, Tanya; Vij, Ravi.
Afiliação
  • Malecek MK; Department of Medicine, Division of Oncology, Washington University School of Medicine, St Louis, MO.
  • Fiala M; Department of Medicine, Division of Oncology, Washington University School of Medicine, St Louis, MO.
  • Schroeder M; Department of Medicine, Division of Oncology, Washington University School of Medicine, St Louis, MO.
  • Dukeman J; Department of Medicine, Division of Oncology, Washington University School of Medicine, St Louis, MO.
  • Ghobadi A; Department of Medicine, Division of Oncology, Washington University School of Medicine, St Louis, MO.
  • Stockerl-Goldstein K; Department of Medicine, Division of Oncology, Washington University School of Medicine, St Louis, MO.
  • Wildes T; Department of Medicine, Division of Oncology, Washington University School of Medicine, St Louis, MO.
  • Vij R; Department of Medicine, Division of Oncology, Washington University School of Medicine, St Louis, MO. Electronic address: rvij@wustl.edu.
Clin Lymphoma Myeloma Leuk ; 18(9): e363-e364, 2018 09.
Article em En | MEDLINE | ID: mdl-30001984
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Mieloma Múltiplo Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Mieloma Múltiplo Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article